摘要 |
The present invention relates to the use of indolinones of general formula
substituted in the 6 position, wherein
R 1 to R 5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases. |